Articles & Video
Gene-Edited Cell Therapies: CMC Challenges and Considerations - WHITEPAPER
This whitepaper reviews the current challenges in manufacturing gene-edited cell therapies and ways to approach them, presenting key case studies.
Technologies and Novel Platforms for Optimizing Cell and Gene Therapies
This interactive ebook explores the unique challenges in the cell and gene therapy industry which are being solved by emerging technology and platforms.
Automating cell and gene therapy manufacturing: challenges and approaches
With the pressure on to scale up manufacturing of cell and gene therapies, what steps should organizations take to optimize their processes with automation? We asked three industry experts for their advice.
42% of pharma industry believe cell and gene therapies to be most promising therapeutics
According to a recent study, 42% of pharma industry professionals predict cell and gene therapies are the therapeutic area that will see the fastest growth in the next 10 years.
Cell and Gene Therapy Report 2020: Viral and Non-viral Vectors
This report of our recent global industry survey reveals the biggest challenges in viral and non-viral vector manufacturing for cell and gene therapies.
Top Biotech Deals in China
Discover the deals transforming China biotech! More than $12 billion in biopharma financing, alliances, IPOs, and new funds have been generated so far this year in China. Learn the details of these deals when you read this new free infographic.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
BioProcess International Spring Digital Week 2020 agenda revealed
We reveal the sessions of the upcoming 7-day webinar series on innovating biopharmaceutical development and production.
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
Latest Cancer Developments and Trends
Discover the latest trends and advancements in cancer treatment in this new article pack from Informa Pharma Intelligence. Inside this downloadable article pack you will discover what is driving oncology dealmaking in 2020.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
A Backstage View Of Roche’s Recent Collaborations
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
Oncology Needs Combo Therapies & More Data Analysis, Says BIO-Europe Spring Panel
Future improvements in cancer care are most likely to stem from combinations therapies and data-driven prevention efforts, as well as breakthrough drugs. That’s the message life sciences experts shared this week during a webcast on the topic of “oncology’s next decade” recorded for the BIO-Europe Spring partnering conference.
Emerging Therapies Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
Why gene therapy lotteries are good for patients, providers, and manufacturers
Jeremy Schafer, PharmD, MBA argues how drug lotteries like Novartis' new program could mean a fairer and more beneficial system for all.
Does Zolgensma’s success predict similar rapid uptake of gene therapy for Hemophilia?
Doe the success of Zolgensma mean payers will be as welcoming to the cost and volume of hemophilia gene therapy or will payers wait for competition?
Measure Twice, Treat Once: Navigating the regulatory landscape of assay development to ensure high-quality CGT products
In this article from BioProcess International, the authors discuss the use of analytical assays in process development and manufacturing of cell and gene therapeutics.